We reach more than 65,000 registered users in Dec!! Register Now

Preventing onset and development of heart failure with preserved ejection fraction
- June 29, 2025
- 1 Views
- 0 Likes
- 0 Comment
An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating institutions has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of effective treatment. The team reports in Circulation, a journal of the American Heart Association, that when the cardioprotective mechanism fails, it promotes the development of HFpEF. Importantly, restoring the mechanism prevents the progression of the condition. The findings provide a promising therapeutic target to prevent and treat this life-threatening disease.
This study was the result of a productive multidisciplinary collaboration,” Mohamed said. “We worked with slices of human hearts affected by HFpEF, a method developed in my lab at Baylor, integrating the findings with the results from studies in mouse and rat models of the condition to better understand what drives this lipid overload.”
The team began by assessing gene changes in hearts from people diagnosed with metabolic stress along with various cardiovascular complications and found alterations in the expression of 488 genes. “We found particularly relevant the simultaneous reduction of the expression of genes XBP1 and EDEM2 in human HFpEF hearts,” Mohamed said.
The link between EDEM2 and other conditions has been studied, but its role in the heart remains unexplored.
“We discovered that the XBP1 protein regulates the Edem2 gene in animal models and that EDEM2 was downregulated in hearts from individuals with metabolic disorders and in mouse models,” Mohamed said. “Further evidence supported the involvement of EDEM2 and XBP1 in cardiovascular diseases and lipid regulation.”
To investigate whether XBP1 and EDEM2 were directly involved in lipid toxicity and HFpEF, the researchers removed the Xbp1 or the Edem2 gene in mice. Consequently, these mice became more vulnerable to metabolic stress-induced heart lipid toxicity and cardiac dysfunction. “It was exciting to see that restoring Xbp1 or Edem2 alleviated lipid overload in the heart and reversed HFpEF,” Mohamed said.
This comprehensive study uncovered that XBP1 and EDEM2 work together to maintain a healthy lipid balance in heart cells.
List of Referenes
- Oveena Fonseka, Rida Raja, Claire Ross, Sanskruti R. Gare, Jiayan Zhang, Susanne S. Hille, Katharine King, Andrea Ruiz-Velasco, Namrita Kaur, Xinyi Chen, Jessica M. Miller, Riham R.E. Abouleisa, Qinghui Ou, Zhiyong Zou, Xiangjun Zhao, Cristian Sotomayor-Flores, Derk Frank, Eileithyia Swanton, Martin R. Pool, Sara Missaglia, Daniela Tavian, Gabriele G. Schiattarella, Tao Wang, Luigi Venetucci, Christian Pinali, Martin K. Rutter, Bernard D. Keavney, Elizabeth J. Cartwright, Tamer M.A. Mohamed, Oliver J. Müller, Wei Liu. XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity. Circulation, 2025; DOI: 10.1161/CIRCULATIONAHA.124.072194
Cite This Article as
No tags found for this post